We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
With the UK’s possible exit from the EU a little over a week away, the Medicines and Healthcare products Regulatory Agency (MHRA) released 16 new and revised guidances to cover a no-deal exit scenario. Read More
Teva Pharmaceuticals has agreed to a patent litigation settlement with Novo Nordisk that would see the generic drugmaker wait until December 2023 to begin marketing its generic version of the type 2 diabetes drug Victoza (liraglutide). Read More
The FDA on Tuesday issued two final guidance documents that the agency hopes will help drug sponsors develop more effective HIV prevention medicines and HIV treatments for children. Read More